132 related articles for article (PubMed ID: 35687134)
61. A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy.
Bai P; Weng X; Quan K; Chen J; Dai Y; Xu Y; Lin F; Zhong J; Wu T; Chen C
Radiat Oncol; 2020 Aug; 15(1):188. PubMed ID: 32746873
[TBL] [Abstract][Full Text] [Related]
62. Network-level dysconnectivity in patients with nasopharyngeal carcinoma (NPC) early post-radiotherapy: longitudinal resting state fMRI study.
Qiu Y; Guo Z; Han L; Yang Y; Li J; Liu S; Lv X
Brain Imaging Behav; 2018 Oct; 12(5):1279-1289. PubMed ID: 29164505
[TBL] [Abstract][Full Text] [Related]
63. Surgical techniques in radiation induced temporal lobe necrosis in nasopharyngeal carcinoma patients.
Alfotih GT; Zheng MG; Cai WQ; Xu XK; Hu Z; Li FC
Neurol Neurochir Pol; 2016; 50(3):172-9. PubMed ID: 27154443
[TBL] [Abstract][Full Text] [Related]
64. Divergent effects of irradiation on brain cortical morphology in patients with nasopharyngeal carcinoma: one-year follow-up study using structural magnetic resonance imaging.
Lv X; Guo Z; Tang L; Li Z; Lin X; Li J; Han L; Qiu Y; Mai H
Quant Imaging Med Surg; 2021 Jun; 11(6):2307-2320. PubMed ID: 34079703
[TBL] [Abstract][Full Text] [Related]
65. Late temporal lobe necrosis in patients with nasopharyngeal carcinoma: evaluation with combined multi-section diffusion weighted and perfusion weighted MR imaging.
Tsui EY; Chan JH; Ramsey RG; Leung TW; Cheung YK; Luk SH; Lai KF; Wong KP; Fong D; Yuen MK
Eur J Radiol; 2001 Sep; 39(3):133-8. PubMed ID: 11566238
[TBL] [Abstract][Full Text] [Related]
66. Radiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.
Zhou GQ; Yu XL; Chen M; Guo R; Lei Y; Sun Y; Mao YP; Liu LZ; Li L; Lin AH; Ma J
PLoS One; 2013; 8(7):e67488. PubMed ID: 23874422
[TBL] [Abstract][Full Text] [Related]
67. Normal Tissue Complication Probability Model for Radiation-induced Temporal Lobe Injury after Intensity-modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Zeng L; Huang SM; Tian YM; Sun XM; Han F; Lu TX; Deng XW
Radiology; 2015 Jul; 276(1):243-9. PubMed ID: 25658039
[TBL] [Abstract][Full Text] [Related]
68. Statin treatment may lower the risk of postradiation epilepsy in patients with nasopharyngeal carcinoma.
Rong X; Yin J; Wang H; Zhang X; Peng Y
Epilepsia; 2017 Dec; 58(12):2172-2177. PubMed ID: 29034463
[TBL] [Abstract][Full Text] [Related]
69. The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106).
Ha B; Cho KH; Moon SH; Lee CG; Keum KC; Kim YS; Wu HG; Kim JH; Ahn YC; Oh D; Noh JM; Lee JH; Kim SH; Kim WT; Oh YT; Kang MK; Kim JH; Kim JY; Cho MJ; Kay CS; Choi JH
Cancer Res Treat; 2019 Jan; 51(1):12-23. PubMed ID: 29397658
[TBL] [Abstract][Full Text] [Related]
70. Parotid perfusion in nasopharyngeal carcinoma patients in early-to-intermediate stage after low-dose intensity-modulated radiotherapy: evaluated by fat-saturated dynamic contrast-enhanced magnetic resonance imaging.
Cheng CC; Chiu SC; Jen YM; Chang HC; Chung HW; Liu YJ; Chiu HC; Chen CY; Huang GS; Juan CJ
Magn Reson Imaging; 2013 Oct; 31(8):1278-84. PubMed ID: 23664679
[TBL] [Abstract][Full Text] [Related]
71. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
72. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
[TBL] [Abstract][Full Text] [Related]
73. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis.
Cheung M; Chan AS; Law SC; Chan JH; Tse VK
Arch Neurol; 2000 Sep; 57(9):1347-52. PubMed ID: 10987903
[TBL] [Abstract][Full Text] [Related]
74. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
[TBL] [Abstract][Full Text] [Related]
75. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
Du T; Xiao J; Qiu Z; Wu K
PLoS One; 2019; 14(7):e0219611. PubMed ID: 31291379
[TBL] [Abstract][Full Text] [Related]
76. The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.
Jin YN; Zhang WJ; Cai XY; Li MS; Lawrence WR; Wang SY; Mai DM; Du YY; Luo DH; Mo HY
Cancer Res Treat; 2019 Jan; 51(1):34-42. PubMed ID: 29409313
[TBL] [Abstract][Full Text] [Related]
77. Dosiomics-based prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Ren W; Liang B; Sun C; Wu R; Men K; Xu Y; Han F; Yi J; Qu Y; Dai J
Phys Med; 2021 Sep; 89():219-225. PubMed ID: 34425512
[TBL] [Abstract][Full Text] [Related]
78. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
[TBL] [Abstract][Full Text] [Related]
79. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
80. Thyroid V
Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
